dihexa cas number Where to Buy CAS No.:

2023;238:e14013

An update literature review in 2022 (search dates: 06/2013 01/2021) identified 63 studies, 53 of which were added to the evidence base The Panel judged that these were a sufficient evidence base from which to construct the majority of the treatment portion of the guideline and algorithm

Schlothauer T, Rueger P, Stracke JO, Hertenberger H, Fingas F, Kling L, et al

The Clinical Context When Novo Nordisk developed CagriSema (cagrilintide combined with semaglutide), tolerability became a significant consideration in their trials

Variables are presented as mean SD

The selfguided group received educational materials, attended six peer meetings over two years, and underwent annual health monitoring without individualized coaching